about
MicroRNAs and Endothelial (Dys) FunctionDepot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewHighly angiogenic peptide nanofibersHuman iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arraysDigital ankle-brachial index technology used in primary care settings to detect flow obstruction: a population based registry studyEvaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCitDifferential effects of a soluble or immobilized VEGFR-binding peptide.Structural analysis of a helical peptide unfolding pathway.β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activityA selective microRNA-based strategy inhibits restenosis while preserving endothelial function.microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.Peptide-modified zwitterionic porous hydrogels for endothelial cell and vascular engineering.Composite scaffold of poly(vinyl alcohol) and interfacial polyelectrolyte complexation fibers for controlled biomolecule delivery.Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptidesTargeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy.Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivoCaMK4 Gene Deletion Induces Hypertension.Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogelsAngiogenesis in chronic obstructive pulmonary disease: a translational appraisalPhysical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS.Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.One-pot Synthesis of Elastin-like Polypeptide Hydrogels with Grafted VEGF-Mimetic Peptides.Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.Effects of physical activity on endothelial progenitor cells (EPCs)Functional role of miRNA in cardiac resynchronization therapy.Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia.Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer.Mineral coatings modulate β-TCP stability and enable growth factor binding and releaseTreatment of hind limb ischemia using angiogenic peptide nanofibersMitochondrial localization unveils a novel role for GRK2 in organelle biogenesis.Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.Impaired neoangiogenesis in β₂-adrenoceptor gene-deficient mice: restoration by intravascular human β₂-adrenoceptor gene transfer and role of NFκB and CREB transcription factors.Femoral Artery Occlusion Increases Muscle Pressor Reflex and Expression of Hypoxia-Inducible Factor-1α in Sensory Neurons.Mitochondria and Angiogenesis.Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide.Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein.Protein-engineered microenvironments can promote endothelial differentiation of human mesenchymal stem cells in the absence of exogenous growth factors.
P2860
Q26775547-C142F46D-8162-4BFD-8464-52EB6256682EQ26799856-34797EB3-9CF8-43F1-AF29-895B5B167E54Q27334887-9B640833-C290-4013-9F23-AF2E3654874AQ28397986-68D687C5-1625-469F-97D8-656C4C8C9384Q28660921-4E022D38-095C-44CB-BDF4-A1669FB2D845Q29395541-336D4DC8-0BA1-4EAB-A55F-B22FD2F6E0F5Q30524090-0FCF4B5C-6064-4DEC-B88D-628C94E5A3EDQ33548401-B0F29F77-8DDA-4F74-9B78-A949440A184CQ34039282-3C528356-DB12-4238-89C7-40BECB49B6C8Q34129012-255A25F7-BD37-4B14-B2B2-AA5B087BCDDAQ34504964-8FFDA0D4-7627-496D-9E46-F5B9E3FBE1F2Q34579343-73D6A775-EF79-4D03-8CB3-F36CCA196430Q35042390-CD669478-1844-4776-AC80-BA8A13ADF0AAQ35246152-66B55E03-A7BD-4FFB-B041-4436833037B2Q35674329-C56B28D7-169A-4356-B3C1-DA4F766AFB05Q36225041-5DEBC47C-6496-462F-A79C-D6B386ABA2C4Q36366241-4C179611-4D7F-455B-8B17-C6842A7BC286Q36418634-57AAD3F8-9446-4B98-8C09-9244BD24BD79Q37058368-9EA9AA67-2929-409C-A4F1-B165ABD485EAQ37086960-E13C5DE0-6E1B-47A4-A987-30221FA96BBAQ37142664-170DCCC1-9C34-482E-B6C8-4979F7CDC968Q37149283-2F617DF4-9461-400B-890A-8F59481F20D1Q37692002-5CEC716A-9A92-49A9-8E54-6CA6F2EB24B2Q37739569-5FAF6251-CB3E-49CA-9E09-98D7BE850FCEQ38093493-1775D5ED-90E3-4272-803D-7D80DEBD8609Q38189347-BBF936FF-EC9D-4727-8A4C-20CEED9EB093Q38236031-4A8CD20D-F405-4592-BA26-ECE1E6B8029CQ38429809-0F858939-5113-4890-8BD9-47333E2F24C6Q38894255-238E4F39-3310-420B-807A-5198A487A521Q38987786-EEC5BF12-E5C5-4E17-BB09-20C9968F574BQ39431113-FFBE6B5F-C817-4DF8-A873-7A0FA19A393CQ39763708-75B86E8E-8F35-4AEC-94BA-0F00AAD7E5F1Q39786555-3524CB70-723C-48B2-BF6B-6F2ADE65D496Q42578299-0B29826C-B291-40A3-89EF-93B9DC5F556AQ42613659-2FD15A64-BA04-4005-AF16-A3CFAF45A3D2Q42957733-78C9F936-E8EC-41F6-B729-303CC50B0175Q46359827-0BAA21E0-A889-4815-B2FD-B5D307068B79Q47880097-5670EECD-8346-48F1-9BB3-21434CB85614Q48162548-37F30835-CBFC-421A-AE29-A479500ADBD8Q48306732-18DF61E2-B56F-4012-9939-AA38A812FDA8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo properties of the proangiogenic peptide QK
@en
In vivo properties of the proangiogenic peptide QK.
@nl
type
label
In vivo properties of the proangiogenic peptide QK
@en
In vivo properties of the proangiogenic peptide QK.
@nl
prefLabel
In vivo properties of the proangiogenic peptide QK
@en
In vivo properties of the proangiogenic peptide QK.
@nl
P2093
P2860
P356
P1476
In vivo properties of the proangiogenic peptide QK
@en
P2093
Alfonso Campanile
Barbara Ziaco
Bruno Trimarco
Carlo Pedone
Federico Piscione
Gaetano Santulli
Gennaro Galasso
Gianluigi Palumbo
Giovanna Giuseppina Altobelli
Guido Iaccarino
P2860
P2888
P356
10.1186/1479-5876-7-41
P577
2009-06-08T00:00:00Z
P5875
P6179
1005452871